Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

389
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
389
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

1.9K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
1.9K
Tumor Progression02:07

Tumor Progression

6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Bone Disorders01:29

Bone Disorders

4.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.5K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An SRF-rearranged malignant cellular myoid neoplasm with a novel SRF-MKL2 fusion.

Pediatric blood & cancer·2023
Same author

Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.

Clinical chemistry and laboratory medicine·2023
Same author

Opioid Use in Surgical Management in Musculoskeletal Oncology.

The Journal of bone and joint surgery. American volume·2023
Same author

The Impact of Implant Fixation Type on Reoperation Rates Following Endoprosthetic Reconstruction Surgery.

The Journal of bone and joint surgery. American volume·2023
Same author

Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors.

The Journal of bone and joint surgery. American volume·2023
Same author

Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.

The Journal of bone and joint surgery. American volume·2023

Related Experiment Video

Updated: Nov 3, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.4K

Synovial Sarcoma: A Clinical Review.

Aaron M Gazendam1, Snezana Popovic2, Sohaib Munir3

  • 1Department of Surgery, Division of Orthopaedic Surgery, McMaster University, Hamilton, ON L8V 1C3, Canada.

Current Oncology (Toronto, Ont.)
|June 2, 2021
PubMed
Summary
This summary is machine-generated.

Synovial sarcoma (SS) is a distinct soft tissue sarcoma (STS) characterized by a specific genetic translocation. Early diagnosis and surgical excision are key, with ongoing research into chemotherapy and targeted therapies for improved outcomes.

Keywords:
clinical reviewcurrent conceptssoft tissue sarcomasynovial sarcoma

More Related Videos

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

5.3K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.8K

Related Experiment Videos

Last Updated: Nov 3, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.4K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

5.3K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.8K

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Synovial sarcoma (SS) comprises 5-10% of soft tissue sarcomas (STS).
  • SS is distinguished by a younger age at diagnosis and unique clinical presentation compared to other STS.
  • The condition is driven by a specific t(X;18) chromosomal translocation, forming SS18:SSX fusion oncogenes.

Purpose of the Study:

  • To provide a comprehensive overview of synovial sarcoma.
  • To discuss diagnostic methods, prognostic factors, and current treatment strategies.
  • To highlight emerging therapeutic avenues based on evolving molecular and immunologic understanding.

Main Methods:

  • Diagnosis involves a combination of clinical evaluation, imaging (MRI), biopsy, and molecular analysis.
  • Prognostic factors such as tumor size, patient age, and grade are assessed.
  • Treatment strategies include surgical excision, adjuvant radiation, and consideration of chemotherapy.

Main Results:

  • Increasing tumor size, patient age, and higher tumor grade are negative predictors for recurrence and metastasis.
  • Wide surgical excision is the primary treatment modality.
  • The role of chemotherapy in SS treatment shows potential survival benefits in specific patient groups.

Conclusions:

  • Synovial sarcoma requires a multidisciplinary diagnostic approach.
  • Surgical management is crucial, with radiation as an adjunct for specific cases.
  • Further research into systemic therapies, informed by molecular insights, is essential for advancing SS treatment.